Immune Activation Markers in HIV-infected Patients Switching to Long Acting Dual Therapy

Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection

NCT04505501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

To Evaluate Effectiveness and Safety of Containing Raltegravir in Naive HIV NON B or B Infected Patients

NCT01162538 ·Status: UNKNOWN

A Chronological Study of the Formation of HIV Cellular Reservoirs Through the Expression of Surface Markers on CD4 + T Lymphocytes, Including CD32a

NCT03298360 ·Status: COMPLETED

Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV

NCT00329251 ·Status: COMPLETED ·Phase: PHASE4

Study of Anti-HIV Therapy Intensification

NCT00034086 ·Status: COMPLETED ·Phase: NA

Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043)

NCT05115838 ·Status: WITHDRAWN ·Phase: PHASE2

Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed

NCT05633927 ·Status: COMPLETED

Vaccines in a Time of Dual Pandemic: COVID-19 Vaccine in People With HIV

NCT06731127 ·Status: COMPLETED

Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes

NCT00440206 ·Status: COMPLETED

Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults

NCT02231281 ·Status: UNKNOWN ·Phase: PHASE3

Combination Vaccination Before HIV Treatment Interruption

NCT00212888 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Cytomegalovirus Infection in Patients With HIV-1 Infection

NCT04067869 ·Status: COMPLETED ·Phase: PHASE3

Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers

NCT00027482 ·Status: COMPLETED

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx

NCT00071890 ·Status: COMPLETED ·Phase: PHASE2

Rapid Build of HIV Related Protective Barriers

NCT03852849 ·Status: UNKNOWN ·Phase: NA

Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women

NCT01812980 ·Status: COMPLETED ·Phase: PHASE4

Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)

NCT01008813 ·Status: COMPLETED ·Phase: PHASE2

Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials

NCT00789789 ·Status: TERMINATED

Analysis of Immune Responses to HIV Vaccines

NCT00068978 ·Status: COMPLETED

Safety, PK and Antiviral Activity of PGT121 Monoclonal Antibody in HIV-uninfected and HIV-infected Adults

NCT02960581 ·Status: COMPLETED ·Phase: PHASE1

Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003)

NCT01353898 ·Status: TERMINATED ·Phase: PHASE1

Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART

NCT01869634 ·Status: COMPLETED ·Phase: PHASE4

Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients

NCT00333892 ·Status: COMPLETED

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

NCT05719441 ·Status: RECRUITING ·Phase: PHASE2

Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients

NCT00672932 ·Status: COMPLETED ·Phase: NA